Eculizumab in the Management of Catastrophic Antiphospholipid Syndrome with Multiorgan Involvement: A Case Report

    May 2025 in “ The Journal of Rheumatology ”
    Laura Salvador Maicas, Roxana González Mazarío, J. J. Fragío Gil … Cristina Campos Fernández
    Studysummary In this case report, researchers detailed the clinical management and positive outcome of a 62-year-old woman with catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus, highlighting the potential effectiveness of Eculizumab in achieving disease remission and maintaining stability over 18 months.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jrheum.org →
    Discuss this study in the Community →